Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Polyethylene Terephthalate
95%
Pediatrics
90%
Fluorodeoxyglucose F 18
58%
Neoplasm
52%
Tumor
47%
Oncology
47%
Radiation Therapy
40%
Cancer
37%
Positron Emission Tomography
36%
Neuroendocrine Tumor
31%
Magnetic Resonance Imaging
31%
Diagnostic Imaging
30%
Diseases
25%
Positron Emission Tomography - Magnetic Resonance Imaging
23%
Arm
22%
Low Drug Dose
21%
Hodgkin's Lymphoma
21%
Breast Cancer
20%
Paraganglioma
20%
Treatment Response
19%
Pheochromocytoma
18%
Somatostatin Receptor
18%
Computer Assisted Tomography
17%
Image Quality
15%
Metastatic Carcinoma
14%
Gallium 68
14%
Gene Mutation
14%
Recurrent Disease
13%
Liver Metastasis
13%
Childhood Cancer
12%
Mitogen-Activated Protein Kinase
12%
Biological Marker
11%
(3 Iodobenzyl)guanidine
11%
Cervical Cancer
11%
Diagnostic Accuracy
11%
Single Photon Emission Computed Tomography-Computed Tomography
11%
Technetium-99
11%
Progression Free Survival
10%
Molecularly Targeted Therapy
10%
Diffuse Large B-Cell Lymphoma
10%
Gynecological Oncology
10%
DNA Template
10%
Kidney Tumour
10%
Thyroid Cancer
10%
Selumetinib
10%
Visceral Fat
10%
Disease Activity
10%
Hematopoietic Stem Cell Transplantation
10%
Dual Energy Computed Tomography
10%
Keyphrases
Positron Emission Tomography/computed Tomography (PET/CT)
61%
Tumor
56%
Oncology
40%
Pediatric
31%
Diagnostic Imaging
30%
PET Image
25%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
25%
Radiation Therapy
23%
Quantitative PET
23%
Lymphoma
22%
Metabolic Tumor Volume
21%
Clinical Practice
21%
Oncologic
20%
Imaging Recommendations
20%
Observer Performance
20%
PET-MRI
20%
Older Adults
20%
Pictorial Review
20%
Central Review
20%
Pediatric MATCH
20%
Phase I Study
20%
Paraganglioma
20%
FDG Uptake
19%
Computed Tomography
18%
Total Lesion Glycolysis
16%
Radiation Dose
16%
High Risk
15%
Hodgkin Lymphoma
15%
Imaging Studies
15%
Working Diagnosis
15%
Pheochromocytoma
15%
PET Segmentation
14%
FDG-PET Imaging
14%
Genetic Modification
14%
95% Confidence Interval
13%
Dice Similarity Coefficient
13%
Malignancy
13%
Pediatric Patients
13%
Multicenter Clinical Trial
13%
Deep Learning
13%
Mitogen-activated Protein Kinase
12%
68Ga-DOTATATE
12%
123I-MIBG
12%
18F-fluorodeoxyglucose (18F-FDG)
12%
Pediatric Oncology
12%
Imaging Standards
12%
Response Predictors
11%
Imaging Review
11%
Diagnostic Accuracy
11%
Therapy Choice
11%